BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 9688181)

  • 21. Expression of CyclinD1, p27kp-1, and bcl-2 in plexiform neurofibroma with and without malignant transformation in neurofibromatosis type 1.
    Thanakit V; Shuangshoti S; Ruangvejvorachai P
    J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S53-7. PubMed ID: 17718269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-parotid facial nerve multiple plexiform neurofibroma in patient with NF1.
    Fadda MT; Verdino G; Mustazza MC; Bartoli D; Iannetti G
    Int J Pediatr Otorhinolaryngol; 2008 May; 72(5):553-7. PubMed ID: 18329107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histopathologically dysplastic neurofibromas in neurofibromatosis 1: diagnostic criteria, prevalence and clinical significance.
    Valeyrie-Allanore L; Ortonne N; Lantieri L; Ferkal S; Wechsler J; Bagot M; Wolkenstein P
    Br J Dermatol; 2008 May; 158(5):1008-12. PubMed ID: 18363759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent genomic imbalances in chromosomes 17, 19, and 22q in peripheral nerve sheath tumours detected by comparative genomic hybridization analysis.
    Koga T; Iwasaki H; Ishiguro M; Matsuzaki A; Kikuchi M
    J Pathol; 2002 May; 197(1):98-107. PubMed ID: 12081210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoprofiles in malignant peripheral nerve sheath tumor: three case reports and literature review.
    Hu SW; Lin WC; Tsai HJ; Chien SH; Tsai KB
    Kaohsiung J Med Sci; 2006 Mar; 22(3):135-42. PubMed ID: 16602278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral Nerve Sheath Tumors in Patients With Neurofibromatosis Type 1: Morphological and Immunohistochemical Study.
    Friedrich RE; Nörnberg LKN; Hagel C
    Anticancer Res; 2022 Mar; 42(3):1247-1261. PubMed ID: 35220215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perineurial malignant peripheral nerve sheath tumor (MPNST): a clinicopathologic, immunohistochemical, and ultrastructural study of seven cases.
    Hirose T; Scheithauer BW; Sano T
    Am J Surg Pathol; 1998 Nov; 22(11):1368-78. PubMed ID: 9808129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant peripheral nerve sheath tumors in neurofibromatosis 1.
    King AA; Debaun MR; Riccardi VM; Gutmann DH
    Am J Med Genet; 2000 Aug; 93(5):388-92. PubMed ID: 10951462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
    Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
    Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plexiform malignant peripheral nerve sheath tumor of infancy and childhood.
    Meis-Kindblom JM; Enzinger FM
    Am J Surg Pathol; 1994 May; 18(5):479-85. PubMed ID: 7513502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components.
    Watanabe T; Oda Y; Tamiya S; Masuda K; Tsuneyoshi M
    J Clin Pathol; 2001 Aug; 54(8):631-6. PubMed ID: 11477120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Size of tooth crowns and position of teeth concerning the extension of facial plexiform neurofibroma in patients with neurofibromatosis type 1.
    Friedrich RE; Giese M; Stelljes C; Froeder C; Scheuer HA
    Anticancer Res; 2012 May; 32(5):2207-14. PubMed ID: 22593511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings.
    Spurlock G; Knight SJ; Thomas N; Kiehl TR; Guha A; Upadhyaya M
    J Cancer Res Clin Oncol; 2010 Dec; 136(12):1869-80. PubMed ID: 20229272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pigmented neurofibroma: review of Japanese patients with an analysis of melanogenesis demonstrating coexpression of c-met protooncogene and microphthalmia-associated transcription factor.
    Motoi T; Ishida T; Kawato A; Motoi N; Fukayama M
    Hum Pathol; 2005 Aug; 36(8):871-7. PubMed ID: 16112003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benign nerve sheath tumors on urinary bladder biopsy.
    Wang W; Montgomery E; Epstein JI
    Am J Surg Pathol; 2008 Jun; 32(6):907-12. PubMed ID: 18425043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Soft-tissue sarcomas in children and adolescents with neurofibromatosis type 1.
    Ferrari A; Bisogno G; Macaluso A; Casanova M; D'Angelo P; Pierani P; Zanetti I; Alaggio R; Cecchetto G; Carli M
    Cancer; 2007 Apr; 109(7):1406-12. PubMed ID: 17330850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytohistologic correlations of 24 malignant peripheral nerve sheath tumor (MPNST) in 17 patients: the Institut Curie experience.
    Klijanienko J; Caillaud JM; Lagacé R; Vielh P
    Diagn Cytopathol; 2002 Aug; 27(2):103-8. PubMed ID: 12203877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nerve sheath tumors of cranial and peripheral nerves].
    Papierz W; Liberski PP
    Pol J Pathol; 2001; 52(4 Suppl):141-56. PubMed ID: 11987602
    [No Abstract]   [Full Text] [Related]  

  • 40. Diffusion-Weighted Magnetic Resonance Imaging Improves the Accuracy of Differentiation of Benign from Malignant Peripheral Nerve Sheath Tumors.
    Koike H; Nishida Y; Ito S; Shimoyama Y; Ikuta K; Urakawa H; Sakai T; Shimizu K; Ito K; Imagama S
    World Neurosurg; 2022 Jan; 157():e207-e214. PubMed ID: 34624521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.